LabCorp launches EXACT's genomic colorectal cancer test
This article was originally published in Clinica
Executive Summary
Laboratory Corporation of America (LabCorp) has made available through its nationwide network a DNA-based colorectal cancer test, PreGen-26. The test, which is based on EXACT Sciences' proprietary genomics-based technology, is intended to detect the presence of the actual disease, rather than being a predictive test for the condition.